Results shown herein are in agreement with this observation, providing the first validation of this mechanism (Rictor/mTORC2 suppression of RhoGDI2 to activate Rac) in HER2-amplified breast cancer cell migration/metastasis. Here, ARHGDIB is linked to breast cancer.